We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
PharmaDesign (PDI) and its representative, Summit
Pharmaceutical International (SPI), have announced that SPI has signed an agreement
with Merck & Co. to license PharmaGPEP, a GPCR peptide ligand library designed
and produced by PDI.
A group of bipartisan senators and representatives have
introduced a bill that would legalize the importation of prescription drugs
into the U.S., as lawmakers say momentum is growing for passing such legislation
this session.
Newly confirmed HHS Secretary Michael Leavitt has announced proposed regulations
that would facilitate the use of electronic prescriptions when the Medicare
drug benefit takes effect next January.
The health department will on March 15 argue that the Constitutional Court should
hear its appeal against a Supreme Court of Appeals ruling scrapping government's
controversial medicine pricing regulations because the lower court did not have
jurisdiction to decide on the matter.
Valeant Pharmaceuticals has signed a definitive agreement to acquire Xcel Pharmaceuticals,
a privately held specialty pharmaceutical company focused on neurology products
in the U.S.
Gov. Christine Gregoire, in her first major initiative to boost Washington's
economy, is pushing to create a $350 million Life Sciences Discovery Fund to
bankroll biomedical research in the state.
Biotechnology firm Protein Design Labs has said it increased the price it will
pay for ESP Pharma after the Edison, N.J.-based drugmaker acquired rights to
a heart attack treatment.
As new technologies are innovated in the pharmaceutical and biotechnology sectors,
the number of fresh patents and related regulations is also on the rise.